OPKO HEALTH, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 18237
 
  
 
C07D HETEROCYCLIC COMPOUNDS 18144
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 491
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 466
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 3135
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C07K PEPTIDES 1135
 
  
 
C40B COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES 121
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2015/0283,121 TABLET FORMULATIONS CONTAINING 8-[-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE SALTS AND TABLETS MADE THEREFROMNov 13, 14Oct 08, 15[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9822116 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compoundsFeb 01, 16Nov 21, 17[C07D, C07C]
9688693 antagonistsJul 25, 14Jun 27, 17[A61K, C07D]
9551721 Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseasesJun 01, 10Jan 24, 17[A61K, C07D, C07C, G01N, A61P, C40B, C07K]
9469629 antagonistsJun 13, 14Oct 18, 16[A61K, C07F, C07D]
9345692 Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxy-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the sameMar 19, 13May 24, 16[A61K]
9260428 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compoundsSep 27, 13Feb 16, 16[C07D]
9249144 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compoundsOct 01, 13Feb 02, 16[C07D, C07C]
9101615 Intravenous formulations of neurokinin-1 antagonistsAug 13, 10Aug 11, 15[A61K]
9006211 Hypersulfated disaccharide formulationsAug 28, 13Apr 14, 15[A61K]
8796299 NK1 antagonistsSep 24, 12Aug 05, 14[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0250,242 HYPERSULFATED DISACCHARIDE FORMULATIONSAbandonedMay 13, 16Sep 01, 16[A61K]
2013/0203,695 HYPERSULFATED DISACCHARIDES TO TREAT ELASTASE RELATED DISORDERSAbandonedOct 27, 11Aug 08, 13[A61K, C13K]
2013/0122,088 TABLET FORMULATIONS CONTAINING 8-[-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE SALTS AND TABLETS MADE THEREFROMAbandonedJan 04, 13May 16, 13[A61K]
2011/0245,197 HYPERSULFATED GLUCOPYRANOSIDESAbandonedMar 29, 11Oct 06, 11[A61K, C07H, A61P]
2010/0303,835 PEPTOID LIGANDS FOR ISOLATION AND TREATMENT OF AUTOIMMUNE T-CELLSAbandonedMay 28, 10Dec 02, 10[A61K, C12N, G01N, A61P, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.